Drexel Morgan & Co.
- SEC CIK
- 0001508512
- Latest filing
- Aug 13, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by Drexel Morgan & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,900
- Value
- $478.1K
- % of portfolio
- 0.1%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,900 | $478.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,900 | $413.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,900 | $434.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,900 | $439.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,900 | $352.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,900 | $398.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,900 | $337.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,900 | $375.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,900 | $325.9K | 0.1% | +291+18.1% | Added | Holders |
| Q1 2024 | 1,609 | $293.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,609 | $249.3K | 0.1% | +259+19.2% | Added | Holders |
| Q3 2023 | 1,350 | $201.2K | 0.1% | +1,350 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −1,350−100.0% | Sold out | Holders |
| Q1 2023 | 1,350 | $215.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,350 | $218.2K | <0.1% | +1,350 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −1,350−100.0% | Sold out | Holders |
| Q2 2022 | 1,350 | $207.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,350 | $219.0K | 0.1% | +1,350 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −4,432−100.0% | Sold out | Holders |
| Q1 2021 | 4,432 | $480.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.